Caio Julio Cesar dos Santos Fernandes

Caio Julio Cesar dos Santos Fernandes

Auto-generated profile, based on publicly available information

Caio Julio Cesar dos Santos Fernandes

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
CFCaio J. Fernandes
Caio J. Fernandes
LMLuciana T. K. Morinaga
Luciana T. K. Morinaga
JAJosé L. Alves
José L. Alves
MCMarcela A. Castro
Marcela A. Castro
DCDaniela Calderaro
Daniela Calderaro
RSRogerio Souza
Rogerio Souza
Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review.

24 March 2009 in Circulation
Verified
Journal Article
Closed access
PDF file
MLMonica Lapa
Monica Lapa
BDBruno Dias
Bruno Dias
CJCarlos Jardim
Carlos Jardim
CFCaio J.C. Fernandes
Caio J.C. Fernandes
PDPaulo M.M. Dourado
Paulo M.M. Dourado
RSRogerio Souza
Rogerio Souza
Background — Schistosomiasis is a highly prevalent disease with >200 million infected people. Pulmonary hypertension is one of the pulmonary manifestations in this disease, particularly in its hepatosplenic presentation. The aim of this study was to determine the prevalence of pulmonary hypertension in schistosomiasis patients with the hepatosplenic form of the disease. Methods and Results — All patients with hepatosplenic schistosomiasis followed up at the gastroenterology department of our university hospital underwent echocardiographic evaluation to search for pulmonary hypertension. Patients presenting with systolic pulmonary artery pressure >40 mm Hg were further evaluated through right heart catheterization. Our study showed an 18.5% prevalence of patients with elevated systolic pulmonary artery pressure at echocardiography. Invasive hemodynamics confirmed the presence of pulmonary hypertension in 7.7% (95% confidence interval, 3.3 to 16.7) of patients, with a prevalence of precapillary (arterial) pulmonary hypertension of 4.6% (95% confidence interval, 1.5 to 12.7). Conclusions — Our study reinforces the role of echocardiography as a screening tool in the investigation of pulmonary hypertension, together with the need for invasive monitoring for a proper diagnosis. We conclude that hepatosplenic schistosomiasis may account for one of the most prevalent forms of pulmonary hypertension worldwide, justifying the development of further studies to evaluate the effect of specific pulmonary hypertension treatment in this particular form of the disease.

1 February 2015 in Chest
Verified
Journal Article
Closed access
PDF file
JAJose Leonidas Alves
Jose Leonidas Alves
FGFrancisca Gavilanes
Francisca Gavilanes
CJCarlos Jardim
Carlos Jardim
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
LMLuciana Tamie Kato Morinaga
Luciana Tamie Kato Morinaga
RSRogerio Souza
Rogerio Souza

1 August 2010 in JACC
Verified
Journal Article
Closed access
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
CJCarlos Vianna Poyares Jardim
Carlos Vianna Poyares Jardim
AHAndre Hovnanian
Andre Hovnanian
SHSusana Hoette
Susana Hoette
BDBruno Arantes Dias
Bruno Arantes Dias
RSRogerio Souza
Rogerio Souza

1 January 2007 in Respiratory Medicine
Verified
Journal Article
Closed access
RSRogerio Souza
Rogerio Souza
CJCarlos Jardim
Carlos Jardim
CFCaio Julio Cesar Fernandes
Caio Julio Cesar Fernandes
MLMonica Silveira Lapa
Monica Silveira Lapa
RRRogerio Rabelo
Rogerio Rabelo
MHMarc Humbert
Marc Humbert

2 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAna Paula Breda
Ana Paula Breda
AAAndre Luis Pereira De Albuquerque
Andre Luis Pereira De Albuquerque
CJCarlos Jardim
Carlos Jardim
LMLuciana Kato Morinaga
Luciana Kato Morinaga
MSMilena Mako Suesada
Milena Mako Suesada
RSRogerio Souza
Rogerio Souza
Pulmonary arterial hypertension is a progressive disease that is characterized by dyspnea and exercise intolerance. Impairment in skeletal muscle has recently been described in PAH, although the degree to which this impairment is solely determined by the hemodynamic profile remains uncertain. The aim of this study was to verify the association of structural and functional skeletal muscle characteristics with maximum exercise in PAH. The exercise capacity, body composition, CT area of limb muscle, quality of life, quadriceps biopsy and hemodynamics of 16 PAH patients were compared with those of 10 controls. PAH patients had a significantly poorer quality of life, reduced percentage of lean body mass, reduced respiratory muscle strength, reduced resistance and strength of quadriceps and increased functional limitation at 6MWT and CPET. VO2 max was correlated with muscular variables and cardiac output. Bivariate linear regression models showed that the association between muscular structural and functional variables remained significant even after correcting for cardiac output. Our study showed the coexistence of ventilatory and quadriceps weakness in face of exercise intolerance in the same group of PAH patients. More interestingly, it is the first time that the independent association between muscular pattern and maximum exercise capacity is evidenced in PAH, independently of cardiac index highlighting the importance of considering rehabilitation in the treatment strategy for PAH.